The widely used osteoporosis drug alendronate can also reduce the risk of developing type 2 diabetes, according to Danish researchers. Those behind a new study said it had been known for decades that patients with diabetes had a higher risk of fractures, suggesting a link…
The post Bisphosphonate ‘may reduce risk’ of developing type 2 diabetes appeared first on Nursing Times.
0 comments:
Post a Comment